KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Liabilities (2016 - 2025)

Biogen (BIIB) has 17 years of Total Liabilities data on record, last reported at $11.2 billion in Q4 2025.

  • For Q4 2025, Total Liabilities fell 1.33% year-over-year to $11.2 billion; the TTM value through Dec 2025 reached $11.2 billion, down 1.33%, while the annual FY2025 figure was $11.2 billion, 1.33% down from the prior year.
  • Total Liabilities reached $11.2 billion in Q4 2025 per BIIB's latest filing, down from $29.2 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $29.2 billion in Q3 2025 and bottomed at $10.7 billion in Q2 2025.
  • Average Total Liabilities over 5 years is $12.7 billion, with a median of $11.7 billion recorded in 2024.
  • Peak YoY movement for Total Liabilities: dropped 19.08% in 2023, then surged 143.89% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $12.9 billion in 2021, then dropped by 13.56% to $11.2 billion in 2022, then increased by 7.88% to $12.0 billion in 2023, then fell by 5.91% to $11.3 billion in 2024, then dropped by 1.33% to $11.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $11.2 billion in Q4 2025, $29.2 billion in Q3 2025, and $10.7 billion in Q2 2025.